204 related articles for article (PubMed ID: 22740226)
1. Chemo re-irradiation in recurrent head and neck cancer: a single institution experience.
Katodritis N; Charalampous H; Vomvas D
J BUON; 2012; 17(2):397. PubMed ID: 22740226
[No Abstract] [Full Text] [Related]
2. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
3. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
4. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial.
Hehr T; Classen J; Belka C; Welz S; Schäfer J; Koitschev A; Bamberg M; Budach W
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1423-31. PubMed ID: 15817346
[TBL] [Abstract][Full Text] [Related]
5. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
[TBL] [Abstract][Full Text] [Related]
6. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
7. Chemo-reirradiation in persistent/recurrent head and neck cancers.
Nagar YS; Singh S; Datta NR
Jpn J Clin Oncol; 2004 Feb; 34(2):61-8. PubMed ID: 15067097
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer.
Watkins JM; Stuart RK; Davis BK; Day TA; Chaudharry UB; Sharma AK
J S C Med Assoc; 2008 Feb; 104(2):36-9. PubMed ID: 18396601
[No Abstract] [Full Text] [Related]
9. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.
Peters LJ; O'Sullivan B; Giralt J; Fitzgerald TJ; Trotti A; Bernier J; Bourhis J; Yuen K; Fisher R; Rischin D
J Clin Oncol; 2010 Jun; 28(18):2996-3001. PubMed ID: 20479390
[TBL] [Abstract][Full Text] [Related]
10. Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy.
Yovino S; Settle K; Taylor R; Wolf J; Kwok Y; Cullen K; Ord R; Zimrin A; Strome S; Suntharalingam M
Head Neck; 2010 Jan; 32(1):46-52. PubMed ID: 19484762
[TBL] [Abstract][Full Text] [Related]
11. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
14. [A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].
Shparyk IaV; Kravets AI; Bilyns'kyĭ BT; Kuftiak OF
Lik Sprava; 1996; (3-4):153-7. PubMed ID: 9035857
[No Abstract] [Full Text] [Related]
15. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.
Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P
Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480
[No Abstract] [Full Text] [Related]
16. Reirradiation in squamous cell head and neck cancer: recent developments and future directions.
Langendijk JA; Bourhis J
Curr Opin Oncol; 2007 May; 19(3):202-9. PubMed ID: 17414637
[TBL] [Abstract][Full Text] [Related]
17. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
Wong SJ; Machtay M; Li Y
J Clin Oncol; 2006 Jun; 24(17):2653-8. PubMed ID: 16763279
[TBL] [Abstract][Full Text] [Related]
18. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
19. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.
Pfister DG; Su YB; Kraus DH; Wolden SL; Lis E; Aliff TB; Zahalsky AJ; Lake S; Needle MN; Shaha AR; Shah JP; Zelefsky MJ
J Clin Oncol; 2006 Mar; 24(7):1072-8. PubMed ID: 16505426
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Ohashi T; Ohnishi M; Tanahashi S; Murai M
Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]